Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use (NCT05191446)
Impact of the Coronavirus 2019 (COVID-19) Pandemic on Patient Outcomes, Telehealth Care Delivery, and Treatment for Unhealthy Alcohol Use in Vulnerable Patients With Advanced Liver Disease Across Two Healthcare Systems
🩺 Plain-English Summary (8th-Grade Level)
The study consists of a randomized controlled trial evaluating the efficacy and feasibility of a stepped alcohol treatment using telemedicine on unhealthy alcohol use in patients with chronic liver disease receiving care in hepatology practices at three sites. Patients who meet eligibility criteria will be randomized to one of two study arms: 1) Stepped Alcohol Treatment (SAT) or, 2) Usual Care (UC). Participants will be randomized separately by site. SAT includes 3 sessions of motivational interviewing followed by referral to addiction medicine for patients who do not reduce unhealthy drinking. Trial outcome measures will be complete at 6 and 12 months following baseline enrollment.
Who can join: Review the eligibility criteria below.
Location: University of california San Francisco — San Francisco, California
Age range: 18 Years
🧪 Interventions in This Study
- Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use (BEHAVIORAL)
- Usual Care (UC) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of california San Francisco — San Francisco, California
- Zuckerberg San Francisco General Hospital — San Francisco, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Diseases
- Liver Cancer Prevention Randomized Control Trial — Houston, Texas
- RESTORE Declined Livers Study — St Louis, Missouri
- Liver Micro Flow - MRI — Madison, Wisconsin
- The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial — Chicago, Illinois
- MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease — Chicago, Illinois
Explore by condition: All Liver Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.